Active Shortage Ophthalmic Ointment Anti-Infective
Bacitracin Ophthalmic Ointme · 557 days since initial FDA posting
Brand: BACITRACIN
FDA lists Bacitracin Ophthalmic Ointme as Active Shortage (Padagis US LLC).
Availability on file: Unavailable
Bacitracin Ophthalmic Ointment: Active Shortage
Unavailable Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Bacitracin Ophthalmic Ointment
- Manufacturer
- Padagis US LLC
- Dosage Form
- Ophthalmic Ointment
- Presentation
- Bacitracin, Ophthalmic Ointment, 3.5 g (NDC 0574-4022-35)
- Package NDC
- 0574-4022-35
Status & Timeline
- Status
- Active Shortage
- Availability
- Unavailable
- First Reported
- Mar 3, 2025
- Last Updated
- Feb 4, 2026
- Therapeutic Category
- Anti-Infective, Ophthalmology
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Shortage is estimated for 20 months
FDA reason on file: Shortage is estimated for 20 months. General shortage guidance lives on the tracker hub.